等待开盘 06-26 09:30:00 美东时间
+5.385
+5.89%
Twist Bioscience posts wider Q2 loss, beats revenue estimates, raises FY26 outlook, and expands gene portfolio.
05-05 01:46
Twist Bioscience (NASDAQ:TWST) sees Q3 sales of $114.000 million-$115.000 million vs $111.371 million analyst estimate.
05-04 19:22
Synthesis of structurally complex and highly-engineered protein sequences to enable acceptance of approximately 99.5% of clonal gene orders and 99.9% of all DNA productsComplex synthesis capabilities to support further
05-04 19:22
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
Market Overview Stocks finished lower last week after a poor market response po...
03-01 22:47
ARK's 2025 winners included Robinhood, AMD and Palantir, while its losers were The Trade Desk, Recursion and Twist.
02-25 04:52
B-Body® platform complements Twist's antibody discovery offering enabling rapid, efficient and precise expression and discovery of complex bispecific antibody therapeuticsPlatform to power high-throughput
02-17 20:09
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp Library Preparation Kit and Twist PCR-Free WGS Library Preparation Kit, each designed to address a
02-10 21:09
Twist Bioscience (NASDAQ:TWST) released its Q1 earnings on Monday, February 2, ...
02-02 20:26
For the second quarter,Twist expects Total revenue of approximately $107 million to $108 million, growth of approximately 16% percent year over year at the midpoint, with sequential growth driven by key NGS accounts
02-02 20:21